Bridging the Gap: A Strategic Event for Life Science Innovators
Life sciences founders are invited to attend a focused, half‑day working session on Tuesday 23 June at Fieldfisher LLP in London, designed for funded life sciences and BioPharma companies navigating the path from investment to revenue.
The session brings together Fieldfisher, Newable and AGENCY Medical Marketing to explore why many funded companies stall commercially and what successful founders do differently when making early commercial decisions.
This is a small, discussion‑led session aimed at founders who want practical insight rather than presentations, with content shaped by the challenges raised in the room.
The afternoon covers:
- Structuring for commercial success: the legal and structural decisions specific to BioPharma and life sciences companies, including platform technology strategies, asset-centric structures, licensing models, and positioning for partnership or exit (Janita Good, Fieldfisher)
- Market selection and commercial sequencing: when to pursue NHS, private, or international routes first, and what you need to be proving at each stage (Keith Jackson, 40+ years scaling MedTech internationally)
- What investors need to see: beyond the pitch, the traction signals and management signals that separate a fundable company from a backable one (Newable investment team)
- Go-to-market positioning: building a commercial narrative that lands with healthcare buyers
Event details
- Date: Tuesday 23 June
- Time: 12:00 – 19:00
(Lunch from 12:00; sessions begin at 13:00; networking drinks from 17:20) - Venue: Fieldfisher LLP, Riverbank House, 2 Swan Lane, London EC4R 3TT
- Cost: Free to attend
- Format: Interactive working session; no preparation required
Places are limited and intended for founders of funded life sciences businesses.
Click here to register your place: https://events.newable.co.uk/events/59/bridging-the-gap
For any questions about attendance or suitability, please contact the team at [email protected]